FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE

The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828

22MA026N Method: Combination Anti-4-1BB Immunotherapy, Radiotherapy, and B Cell Activation Therapy